Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6
- PMID: 19365571
- PMCID: PMC2666773
Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6
Abstract
Purpose: To identify mutations in the carbohydrate sulfotransferase gene (CHST6) for a Chinese family with macular corneal dystrophy (MCD) and to investigate the histopathological changes in the affected cornea.
Methods: A corneal button of the proband was obtained by penetrating keratoplasty. The half button and ultrathin sections from the other half button were examined with special stains under a light microscope (LM) and an electron microscope (EM) separately. Genomic DNA was extracted from peripheral blood of 11 family members, and the coding region of CHST6 was amplified by the polymerase chain reaction (PCR) method. The PCR products were analyzed by direct sequencing and restriction enzyme digestion.
Results: The positive reaction to colloidal iron stain (extracellular blue accumulations in the stroma) was detected under light microscopy. Transmission electron microscopy revealed the enlargement of smooth endoplasmic reticulum and the presence of intracytoplasmic vacuoles. The compound heterozygous mutations, c.892C>T and c.1072T>C, were identified in exon 3 of CHST6 in three patients. The two transversions resulted in the substitution of a stop codon for glutamine at codon 298 (p.Q298X) and a missense mutation at codon 358, tyrosine to histidine (p.Y358H). The six unaffected family individuals carried alternative heterozygous mutations. These two mutations were not detected in any of the 100 control subjects.
Conclusions: Those novel compound heterozygous mutations were thought to contribute to the loss of CHST6 function, which induced the abnormal metabolism of keratan sulfate (KS) that deposited in the corneal stroma. It could be proved by the observation of a positive stain reaction and the enlarged collagen fibers as well as hyperplastic fibroblasts under microscopes.
Figures







Similar articles
-
[Novel CHST6 compound heterozygous mutations cause macular corneal dystrophy in a Chinese family].Zhonghua Yan Ke Za Zhi. 2010 Feb;46(2):161-5. Zhonghua Yan Ke Za Zhi. 2010. PMID: 20388351 Chinese.
-
Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy.Invest Ophthalmol Vis Sci. 2002 Feb;43(2):377-82. Invest Ophthalmol Vis Sci. 2002. PMID: 11818380
-
Truncating mutations in the carbohydrate sulfotransferase 6 gene (CHST6) result in macular corneal dystrophy.Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2949-53. doi: 10.1167/iovs.02-0740. Invest Ophthalmol Vis Sci. 2003. PMID: 12824236
-
Analysis of TGFBI gene mutations in Chinese patients with corneal dystrophies and review of the literature.Mol Vis. 2010 Jun 30;16:1186-93. Mol Vis. 2010. PMID: 20664689 Free PMC article. Review.
-
Macular Corneal Dystrophy: An Updated Review.Curr Eye Res. 2021 Jun;46(6):765-770. doi: 10.1080/02713683.2020.1849727. Epub 2020 Nov 29. Curr Eye Res. 2021. PMID: 33171054 Review.
Cited by
-
Characteristics of corneal dystrophies: a review from clinical, histological and genetic perspectives.Int J Ophthalmol. 2016 Jun 18;9(6):904-13. doi: 10.18240/ijo.2016.06.20. eCollection 2016. Int J Ophthalmol. 2016. PMID: 27366696 Free PMC article. Review.
-
Novel compound heterozygous mutations in the CHST6 gene cause macular corneal dystrophy in a Han Chinese family.Ann Transl Med. 2021 Apr;9(8):622. doi: 10.21037/atm-20-7178. Ann Transl Med. 2021. PMID: 33987320 Free PMC article.
-
Molecular analysis of the CHST6 gene in Korean patients with macular corneal dystrophy: Identification of three novel mutations.Mol Vis. 2015 Oct 26;21:1201-9. eCollection 2015. Mol Vis. 2015. PMID: 26604660 Free PMC article.
-
Rare stromal corneal dystrophic diseases in Oman: A clinical and histopathological analysis for accurate diagnosis.Oman J Ophthalmol. 2020 May 28;13(2):70-75. doi: 10.4103/ojo.OJO_283_2019. eCollection 2020 May-Aug. Oman J Ophthalmol. 2020. PMID: 32792801 Free PMC article.
-
A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy.Aging (Albany NY). 2019 Feb 4;11(3):1019-1029. doi: 10.18632/aging.101807. Aging (Albany NY). 2019. PMID: 30716718 Free PMC article.
References
-
- Donnenfeld ED, Cohen EJ, Ingraham HJ, Poleski SA, Goldsmith E, Laibson PR. Corneal thinning in macular corneal dystrophy. Am J Ophthalmol. 1986;101:112–3. - PubMed
-
- Klintworth GK, Oshima E, Al-Rajhi A, Al-Saif A, Thonar EJ, Karcioglu ZA. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype. Am J Ophthalmol. 1997;124:9–18. - PubMed
-
- Jonasson F, Oshima E, Thonar EJMA, Smith CF, Johannson JH, Klintworth GK. Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients. Ophthalmology. 1996;103:1111–7. - PubMed
-
- Yang CJ, SundarRaj N, Thonar EJ, Klintworth GK. Immunohistochemical evidence of heterogeneity in macular corneal dystrophy. Am J Ophthalmol. 1988;106:65–71. - PubMed
-
- Edward DP, Yue BY, Sugar J, Thonar EJ. SunderRaj N, Stock EL, Tso MO. Heterogeneity in macular corneal dystrophy. Arch Ophthalmol. 1988;106:1579–83. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases